Filter by
Filter by
Proton Beam Therapy for Treating Patients with Hepatocellular Carcinoma with Major Portal Vein Tumor Invasion: A Single Center Retrospective Study.
This study from Japan reported favorable results of PBT in treatment of 116 patients with hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT...
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.
This multicenter study led by the MGH group retrospectively analyzed 96 patients with unresectable intrahepatic cholangiocarcinoma (ICC) treated with...
Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma.
This study by the group from Samsung Medial Center, Korea, compared the oncological outcomes of 323 patients with newly diagnosed hepatocellular carcinoma (HCC)...
Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer.
Ninety-day mortality (90DM) is an important measure of the postoperative (nononcologic) outcome as proxy of quality-of-care. This study by the MD Anderson group...
Dosimetric Correlation of Acute Radiation Dermatitis in Patients With Breast Cancer Undergoing Hypofractionated Proton Beam Therapy Using Pencil Beam Scanning.
This study from Taiwan reported acute radiation dermatitis of 42 patients with breast cancer who received adjuvant hypofractionated PBT of 26 GyRBE in five...
Bone Marrow Sparing by Intensity Modulated Proton Beam Therapy in Postoperative Irradiation of Gynecologic Malignancies.
This matched-pair cohort study from the Heidelberg group evaluated IMPT for 25 patients with uterine cervical (n = 8) or endometrial cancer (n = 17), comparing...
Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.
This study from Japan included 100 patients with localized prostate cancer treated with moderately hypofractionated PT (70 GyRBE in 28 fractions) for evaluation...